Global Biopharmaceutical Company | Incyte. com Incyte is a global biopharmaceutical company that has created a robust and diversified portfolio of marketed products and clinical candidates in oncology and inflammation and autoimmunity
Headquarters - Pharmaceutical Research Development | Incyte Find directions to Incyte corporation’s Wilmington Delaware headquarters and European headquarters in Geneva Switzerland Visit Incyte com for more information Also find links to the US map and the map of the European headquarters
Incyte Highlights Commercial Growth, Clinical Progress and 2025 . . . WILMINGTON, Del -- (BUSINESS WIRE)--Jan 13, 2025-- Incyte (Nasdaq:INCY) will provide an update on commercial growth, clinical progress and significant 2025 catalysts during a presentation today at 10:30 a m PT at the 43rd Annual J P Morgan Healthcare Conference in San Francisco